←
ASTCT8,113 posts
ASTCT avatar✓

ASTCT ✓

@ASTCT

The American Society for Transplantation and Cellular Therapy Scientific Journal: @ASTCT_Journal #Tandem27

◷ Joined April 2013▧ 4,618 Photos and videos
ASTCT avatar
ASTCT@ASTCT·15h

Can CD123-directed CAR T-cell therapy safely target relapsed or refractory acute myeloid leukemia (AML) and blastic plasmacytoid dendritic cell neoplasm (BPDCN)? Results from a phase I trial suggest that CD123-targeted CAR T cells can be administered without the prolonged myeloablation predicted by earlier preclinical studies. While remissions were limited and often short-lived, the findings provide important insights into the safety, feasibility, and future development of CAR T-cell therapy for myeloid malignancies. Read more: ow.ly/3uiw5105URK

Post attachment
ASTCT avatar
ASTCT@ASTCT·23h

The ASTCT SIG Travel Grant program awards grants to selected members of the following Special Interest Groups (SIGs) to allay the costs of attending the 2027 Tandem Meetings: •Advanced Practice Professional •Nursing •Pharmacy Deadline Dec 12. Learn more and apply: ow.ly/xJ2o5105UNH

Post attachment
ASTCT avatar
ASTCT@ASTCT·Nov 17

Join the ASTCT Pharmacy SIG on Nov. 18 for a Journal Club discussion of recent literature impacting transplantation and cellular therapy pharmacy practice. Madeleine Hosick, PharmD, of Duke University Hospital, and Olivia Robida, PharmD, of The Ohio State University Wexner Medical Center will review key findings from the featured publication and discuss their implications for clinical practice and patient care. Register: learn.astct.org/products/ast…

Post attachment
ASTCT avatar
ASTCT@ASTCT·Nov 16

Can less antibiotic exposure lead to better outcomes after transplant? In this ASTCT Talks podcast episode, Diego R. Hijano, MD, MSc, Gabriela Marón, MD, MSc, and Fareed Khawaja, MBBS, discuss emerging data on antibiotic de-escalation, microbiome preservation, antimicrobial resistance, and evolving approaches to infection management in hematopoietic cell transplantation. Tune in: ow.ly/JATU5105UIw

Post attachment
ASTCT avatar
ASTCT@ASTCT·Nov 15

How are emerging HSC manipulation strategies transforming transplantation and gene therapy? Join John DiPersio, MD, PhD and Hans-Peter Kiem, MD, PhD for this #Tandem27 session exploring innovative approaches, clinical applications and the latest research advances. Register: ow.ly/PYMN5105bGa

Post attachment
ASTCT avatar
ASTCT@ASTCT·Nov 15

Coming up this week: ASTCT's Pharmacy Journal Club webinar. Join Drs. Hosick and Robida on Nov. 18 for discussion and analysis of current literature impacting pharmacy in transplantation and cellular therapy. Register: ow.ly/y3RU5105bxZ

Post attachment
ASTCT avatar
ASTCT@ASTCT·Nov 14

#Tandem27 Grant Opportunity: The Jeff Gordon Children's Foundation Travel Grants will provide travel grants to 10 young investigators who meet the following criteria: ✅ Is a medical resident, fellow, or within five years of their initial faculty appointment ✅ Is attending the 2027 Tandem Meetings in person ✅ Treats or conducts research in pediatric populations ✅ Has not been previously awarded Award open to U.S. and international applicants; deadline Nov. 9. 🔗ow.ly/SOGb5105bsK

Post attachment
ASTCT avatar
ASTCT@ASTCT·Nov 13

Should fitness for CAR T-cell therapy and transplantation be defined differently? In their latest thought leadership article on Nucleus, Marco Ruiz, MD, and Marc J. Braunstein, MD, PhD, FACP, FASCO, argue for treatment-specific, multidimensional approaches to frailty assessment that move beyond age, performance status, and comorbidity scores alone Read the article: ow.ly/IMJv5105bg1

Post attachment
ASTCT avatar
ASTCT@ASTCT·Nov 13

Presenting your research at #Tandem27? Check out the Tandem Abstract Travel Grant opportunity and see if you qualify for funding. You can apply for a travel grand ahead of abstract notifications for the meetings Apply by Dec. 14: ow.ly/stUz5105bc0

Post attachment
ASTCT avatar
ASTCT@ASTCT·Nov 13

The Call for Volunteers closes today. Help shape Society programs and initiatives while building meaningful connections across the field. Submit your interest before the deadline: astct.org/Membership/Volunte…

Post attachment
ASTCT avatar
ASTCT@ASTCT·Nov 12

ASTCT is still accepting volunteer applications for multiple committees making an impact across the Society. The Call for Volunteers closes tomorrow on Nov. 13. Learn more and submit your interest: ow.ly/4w9z5105aI4

Post attachment
ASTCT avatar
ASTCT@ASTCT·Nov 12

How should clinicians navigate donor selection in an increasingly complex transplantation landscape? In this Nucleus Q&A, Antonio Jiménez-Jiménez, MD, discusses the latest NMDP/CIBMTR recommendations for allogeneic hematopoietic cell donor selection, including advances in HLA matching, donor characteristics, graft source considerations, and key factors shaping donor selection decisions in contemporary practice. Read the interview: ow.ly/r6HK5105aY3

Post attachment
ASTCT avatar
ASTCT@ASTCT·Nov 11

As we approach the Thanksgiving season, Margy MacMillan, MD, MSc, FRCPC, reminds us of the privilege of caring for patients and the power of the community that makes transplantation and cellular therapy possible. Read on Nucleus the latest President’s Message on gratitude, collaboration, and the shared mission that drives ASTCT members every day. ow.ly/YoJ45105aNF

Post attachment
ASTCT avatar
ASTCT@ASTCT·Nov 11

ASTCT is now accepting Volunteer applications for multiple committees making an impact across the Society. The Call for Volunteers closes soon on Nov. 13. Learn more and submit your interest: ow.ly/kvg75105aI2

Post attachment
ASTCT avatar
ASTCT@ASTCT·Nov 11

As cellular therapies expand across hematologic malignancies, solid tumors, and autoimmune diseases, understanding and managing treatment-related toxicities has never been more important. In this Healio Q&A, Sergio A. Giralt, MD, FACP, FASTCT discusses the upcoming 5th International Conference on Toxicities of Transplantation and Cellular Therapies taking place on Nov. 13-14 in Chicago, highlighting emerging toxicities, multidisciplinary approaches to toxicity management, care for older adults, and the research needed to improve the safety and tolerability of transplantation and cellular therapies. Read more: ow.ly/BF225105atL

Post attachment